← Leaderboards
Carl Nicholas Hodge
Seachange Pharmaceuticals, Inc.
$730,552
Attributed
$1,461,103
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $757.4K · FY2011–14$1M$750K$500K$250K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$1,461,103 · 3
By mechanism
R44$909,637 · 1
R43$551,466 · 2
Top collaborators
- Michael James Keiser4 shared
Most similar at Seachange Pharmaceuticals, Inc.
Same institution · by research overlap
- Michael James Keiser$933,052
Others in their field
Top investigators on “Collaborations”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$557,285,233
- David Heimbrook · Leidos Biomedical Research, Inc.$519,426,565
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$479,076,140
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Albert Lazzarini · California Institute Of Technology$382,990,355
Research focus
CollaborationsSmall MoleculeDrug DiscoveryInterestLigandsPharmaceutical PreparationsLettersBaseAnimalsAdverse ReactionsCatalogsCellsChemical StructureClinical TrialsCatalogingBiologyAnimal ModelDatabasesDescriptorDesignDrug CandidateDrug Delivery SystemsComputing MethodologiesBiological
Grant awards (4)
A platform to predict side-effect targets for drugs$453,470
R44 · FY2014 · GM · contact PI
A platform to predict side-effect targets for drugs$456,167
R44 · FY2013 · GM · contact PI
Relating GPCRs by biased ligands for enhanced therapeutic efficacy$301,225
R43 · FY2013 · MH
Calculating target bias in small molecules for library design$250,241
R43 · FY2011 · GM